These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 37077408)
21. Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant. Ren W; Zhang Y; Rao J; Wang Z; Lan J; Liu K; Zhang X; Hu X; Yang C; Zhong G; Zhang R; Wang X; Shan C; Ding Q mBio; 2023 Apr; 14(2):e0041623. PubMed ID: 37010428 [TBL] [Abstract][Full Text] [Related]
22. Comparative Analysis of Conformational Dynamics and Systematic Characterization of Cryptic Pockets in the SARS-CoV-2 Omicron BA.2, BA.2.75 and XBB.1 Spike Complexes with the ACE2 Host Receptor: Confluence of Binding and Structural Plasticity in Mediating Networks of Conserved Allosteric Sites. Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G Viruses; 2023 Oct; 15(10):. PubMed ID: 37896850 [TBL] [Abstract][Full Text] [Related]
23. Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs. Niu S; Zhao Z; Liu Z; Rong X; Chai Y; Bai B; Han P; Shang G; Ren J; Wang Y; Zhao X; Liu K; Tian W-x; Wang Q; Gao GF J Virol; 2024 Mar; 98(3):e0115723. PubMed ID: 38305152 [TBL] [Abstract][Full Text] [Related]
24. AlphaFold2-Enabled Atomistic Modeling of Structure, Conformational Ensembles, and Binding Energetics of the SARS-CoV-2 Omicron BA.2.86 Spike Protein with ACE2 Host Receptor and Antibodies: Compensatory Functional Effects of Binding Hotspots in Modulating Mechanisms of Receptor Binding and Immune Escape. Raisinghani N; Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G J Chem Inf Model; 2024 Mar; 64(5):1657-1681. PubMed ID: 38373700 [TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike - ACE2 complexes reveal distinct changes between both variants. Socher E; Heger L; Paulsen F; Zunke F; Arnold P Comput Struct Biotechnol J; 2022; 20():1168-1176. PubMed ID: 35251533 [TBL] [Abstract][Full Text] [Related]
26. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1. Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765 [TBL] [Abstract][Full Text] [Related]
27. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion. Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815 [TBL] [Abstract][Full Text] [Related]
29. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain. Pitsillou E; Liang JJ; Beh RC; Hung A; Karagiannis TC Comput Biol Med; 2022 Oct; 149():106035. PubMed ID: 36055162 [TBL] [Abstract][Full Text] [Related]
30. ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Isobe A; Arai Y; Kuroda D; Okumura N; Ono T; Ushiba S; Nakakita SI; Daidoji T; Suzuki Y; Nakaya T; Matsumoto K; Watanabe Y Commun Biol; 2022 Nov; 5(1):1188. PubMed ID: 36335195 [TBL] [Abstract][Full Text] [Related]
31. How Do Point Mutations Enhancing the Basic Character of the RBDs of SARS-CoV-2 Variants Affect Their Transmissibility and Infectivity Capacities? Barre A; Klonjkowski B; Benoist H; Rougé P Viruses; 2022 Apr; 14(4):. PubMed ID: 35458513 [TBL] [Abstract][Full Text] [Related]
32. Ensemble-Based Mutational Profiling and Network Analysis of the SARS-CoV-2 Spike Omicron XBB Lineages for Interactions with the ACE2 Receptor and Antibodies: Cooperation of Binding Hotspots in Mediating Epistatic Couplings Underlies Binding Mechanism and Immune Escape. Raisinghani N; Alshahrani M; Gupta G; Verkhivker G Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673865 [TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins. Matthews AM; Biel TG; Ortega-Rodriguez U; Falkowski VM; Bush X; Faison T; Xie H; Agarabi C; Rao VA; Ju T PLoS One; 2022; 17(12):e0278294. PubMed ID: 36472974 [TBL] [Abstract][Full Text] [Related]
34. Heparin-Induced Allosteric Changes in SARS-CoV-2 Spike Protein Facilitate ACE2 Binding and Viral Entry. Petitjean SJL; Eeckhout S; Delguste M; Zhang Q; Durlet K; Alsteens D Nano Lett; 2023 Dec; 23(24):11678-11684. PubMed ID: 38055954 [TBL] [Abstract][Full Text] [Related]
35. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies. Shah M; Woo HG Front Immunol; 2021; 12():830527. PubMed ID: 35140714 [TBL] [Abstract][Full Text] [Related]
36. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin. Partridge LJ; Urwin L; Nicklin MJH; James DC; Green LR; Monk PN Cells; 2021 Jun; 10(6):. PubMed ID: 34200372 [TBL] [Abstract][Full Text] [Related]
37. Structural basis of increased binding affinities of spikes from SARS-CoV-2 Omicron variants to rabbit and hare ACE2s reveals the expanding host tendency. Shi K; Li L; Luo C; Xu Z; Huang B; Ma S; Liu K; Yu G; Gao GF mBio; 2024 Feb; 15(2):e0298823. PubMed ID: 38112468 [TBL] [Abstract][Full Text] [Related]
38. Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex. Ching WY; Adhikari P; Jawad B; Podgornik R Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077490 [TBL] [Abstract][Full Text] [Related]
39. High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses. Sims JJ; Lian S; Meggersee RL; Kasimsetty A; Wilson JM PLoS One; 2022; 17(8):e0271359. PubMed ID: 36006993 [TBL] [Abstract][Full Text] [Related]
40. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]